First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.
Tóth
A
A
Kispál
Gy
G
Ungvári
E
E
Violka
M
M
Szeberin
Z
Z
Pászti
J
J
Molnár
K
K
Gacs
M
M
Füzi
M
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D055499:Catheter-Related Infections / Q000188:drug therapy / Q000382:microbiology; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D006801:Humans; D006814:Hungary; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy / Q000382:microbiology*; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin